SURG'X
LIVE

Serial Number

79418880

Owner

SURG'X

Attorney

Scott J. Major

Filing Date

Jan 29, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SURG'X Trademark

Serial Number: 79418880 • Registration: 8026684

SURG'X is a trademark filed by SURG'X on January 29, 2025. The trademark is classified under Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SURG'X

26 Rue Barthélémy de Laffemas,

Entity Type: 98

Trademark Details

Filing Date

January 29, 2025

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Veterinary apparatus and instruments, particularly devices, instruments and implants comprising artificial material exclusively for use in veterinary surgery; structural parts and accessories for all the aforesaid goods

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 25, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 7, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 7, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 17, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 17, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 10, 2025 RFCR
NON-FINAL ACTION WRITTEN
Jul 9, 2025 CNRT
ASSIGNED TO EXAMINER
Jul 9, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 16, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 13, 2025 REPR